Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma

Journal of Clinical Oncology

Volumn 24, Issue 10, 2006, Pages 1522-1528

  Tabori, Uri ^a   Ma, Jing ^a   Carter, Michael ^a   Zielenska, Maria ^a   Rutka, James ^a   Bouffet, Eric ^a   Bartels, Ute ^a   Malkin, David ^a   Hawkins, Cynthia ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE; DNA BINDING PROTEIN; TELOMERASE;

ADOLESCENT; ARTICLE; CANCER GRADING; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE FREE SURVIVAL; ENZYME ACTIVITY; EPENDYMOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROSURGERY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY; AGE; BRAIN TUMOR; CHEMISTRY; MORTALITY; PRESCHOOL CHILD; RISK FACTOR; TUMOR RECURRENCE;

ADOLESCENT; AGE FACTORS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DNA-BINDING PROTEINS; EPENDYMOMA; FEMALE; HUMANS; INFANT; MALE; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RISK FACTORS; TELOMERASE;

EID: 33645741644     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.2127     Document Type: Article

References (39)

1. Gilles FH, Sobel EL, Tavare CJ, et al: Age-related changes in diagnoses, histological features, and survival in children with brain tumors: 1930-1979. The Childhood Brain Tumor Consortium. Neurosurgery 37:1056-1068, 1995
2. Pollack IF: Brain tumors in children. N Engl J Med 331:1500-1507, 1994
3. Bouffet E, Perilongo G, Canete A, et al: Intracranial ependymomas in children: A critical review of prognostic factors and a plea for cooperation. Med Pediatr Oncol 30:319-329, 1998
4. Hamilton RL, Pollack IF: The molecular biology of ependymomas. Brain Pathol 7:807-822, 1997
5. Packer RJ: New insights into childhood ependymomas. Curr Neurol Neurosci Rep 5:107-109, 2005
6. Rickert CH, Paulus W: Prognosis-related histomorphological and immunohistochemical markers in central nervous system tumors of childhood and adolescence. Acta Neuropathol (Berl) 109:69-92, 2005
7. Grill J, Le Deley MC, Gambarelli D, et al: Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: A multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol 19:1288-1296, 2001
8. Horn B, Heideman R, Geyer R, et al: A multi-institutional retrospective study of intracranial ependymoma in children: Identification of risk factors. J Pediatr Hematol Oncol 21:203-211, 1999
9. Robertson PL, Zeltzer PM, Boyett JM, et al: Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: A report of the Children's Cancer Group. J Neurosurg 88:695-703, 1998
10. Goldwein JW, Glauser TA, Packer RJ, et al: Recurrent intracranial ependymomas in children: Survival, patterns of failure, and prognostic factors. Cancer 66:557-563, 1990
11. Grill J, Pascal C, Chantal K: Childhood ependymoma: A systematic review of treatment options and strategies. Paediatr Drugs 5:533-543, 2003
12. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100:57-70, 2000
13. Gertler R, Rosenberg R, Stricker D, et al: Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma. J Clin Oncol 22:1807-1814, 2004
14. Hakin-Smith V, Jellinek DA, Levy D, et al: Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet 361: 836-838, 2003
15. Poremba C, Scheel C, Hero B, et al: Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: A molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues. J Clin Oncol 18:2582-2592, 2000
16. Sanders RP, Drissi R, Billups CA, et al: Telomerase expression predicts unfavorable outcome in osteosarcoma. J Clin Oncol 22:3790-3797, 2004
17. Ray A, Ho M, Ma J, et al: A clinicobiological model predicting survival in medulloblastoma. Clin Cancer Res 10:7613-7620, 2004
18. Wiestler OD, Schiffer D, Coons SW, et al: Ependymoma, in Kleihues P, Cavenee WK (eds): Tumours of the Nervous System. Lyon, France, IARC Press, 2000, pp 72-81
19. Camp RL, Charette LA, Rimm DL: Validation of tissue microarray technology in breast carcinoma. Lab Invest 80:1943-1949, 2000
20. Hoos A, Cordon-Cardo C: Tissue microarray profiling of cancer specimens and cell lines: Opportunities and limitations. Lab Invest 81:1331-1338, 2001
21. Yan P, Benhattar J, Seelentag W, et al: Immunohistochemical localization of hTERT protein in human tissues. Histochem Cell Biol 121:391-397, 2004
22. Streutker CJ, Thorner P, Fabricius N, et al: Telomerase activity as a prognostic factor in neuroblastomas. Pediatr Dev Pathol 4:62-67, 2001
23. Fouladi M, Baruchel S, Chan H, et al: Use of adjuvant ICE chemotherapy in the treatment of anaplastic ependymomas. Childs Nerv Syst 14:590-595, 1998
24. Duffner PK, Horowitz ME, Krischer JP, et al: Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328:1725-1731, 1993
25. Grill J, Sainte-Rose C, Jouvet A, et al: Treatment of medulloblastoma with postoperative chemotherapy alone: An SFOP prospective trial in young children. Lancet Oncol 6:573-580, 2005
26. Verstovsek S, Manshouri T, Smith FO, et al: Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: Comparison with adult acute myeloid leukemia. Cancer 97:2212-2217, 2003
27. Teo C, Nakaji P, Symons P, et al: Ependymoma. Childs Nerv Syst 19:270-285, 2003
28. Carrie C, Mottolese C, Bouffet E, et al: Non-metastatic childhood ependymomas. Radiother Oncol 36:101-106, 1995
29. Healey EA, Barnes PD, Kupsky WJ, et al: The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery 28:666-671, 1991
30. Merchant TE, Mulhern RK, Krasin MJ, et al: Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol 22:3156-3162, 2004
31. Shuangshoti S, Rushing EJ, Mena H, et al: Supratentorial extraventricular ependymal neoplasms: A clinicopathologic study of 32 patients. Cancer 103: 2598-2605, 2005
32. Wolfsberger S, Fischer I, Hoftberger R, et al: Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma. Am J Surg Pathol 28:914-920, 2004
33. Zamecnik J, Snuderl M, Eckschlager T, et al: Pediatric intracranial ependymomas: Prognostic relevance of histological, immunohistochemical, and flow cytometric factors. Mod Pathol 16:980-991, 2003
34. Rushing EJ, Yashima K, Brown DF, et al: Expression of telomerase RNA component correlates with the MIB-1 proliferation index in ependymomas. J Neuropathol Exp Neurol 56:1142-1146, 1997
35. Carter M, Nicholson J, Ross F, et al: Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. Br J Cancer 86:929-939, 2002
36. Dyer S, Prebble E, Davison V, et al: Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. Am J Pathol 161: 2133-2141, 2002
37. Gilbertson RJ, Bentley L, Hernan R, et al: ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease. Clin Cancer Res 8:3054-3064, 2002
38. Seimiya H, Muramatsu Y, Ohishi T, et al: Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics. Cancer Cell 7:25-37, 2005
39. Shay JW: Meeting report: The role of telomeres and telomerase in cancer. Cancer Res 65: 3513-3517, 2005